Cardiotext Logo
Hello, Guest.
Cardiotext Rewards Program Free Shipping on domestic orders of $99.00 or more McAfee Secure sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
Product Detail

Heart Failure: Pharmacologic Management

Edited by: Arthur M. Feldman


Shipping Calculator

Request a Quote for 10+ Copies

Tell A Friend

More Info...
Heart Failure: Pharmacologic Management Retail Price: $105.95
Cardiotext Price: $103.83

Availability: Processing time varies. Price is tentative.

Alert me when this product is available
Availability Questions?


Product Information:
ISBN-13: 9781405103619
ISBN-10: 1405103612
Publisher: Wiley-Blackwell
Format: Hardback, 304 pages
Pub Date: 05/2006
Edition Number: 1




Synopsis

Now there is an up-to-date guide for optimizing pharmacologic therapy in treating patients with heart failure. Reflecting current practice at leading medical centers, Heart Failure: Pharmacologic Management provides both the biologic and pathologic underpinnings of each pharmacologic agent in current use. It also supplies detailed discussions of the clinical investigations that support current understanding of the risks and benefits associated with the use of these drugs. Thorough references make the book useful to the novice as well as the experienced clinician.


Initial chapters focus on agents that are considered standard care:


* diuretics

* ACE inhibitors

* angiotensin receptor antagonists

* aldosterone antagonists

* beta-blockers



The discussion moves to agents currently under investigation:


* Vasopressin antagonists

* erythropoietin



Next, the authors consider some controversial drugs:


* inotropic agents

* antiarrhythmic drugs

* anticoagulants



An insightful examination of pharmacogenetics considers:


* how studies of the genetic profile of patients helps determine which patient populations are most likely to respond to a given class of drugs

* the potential use of pharmacogenetics to tailor a pharmacologic regimen for maximum benefit and minimum risk



Multidrug pharmacy for heart failure therapy


An extremely helpful concluding chapter provides a roadmap of drugs with which to approach the patient with heart failure, along with an overview of the skills you need to use it most effectively. This straightforward, step-by-step algorithm will save you countless hours of research and help you make your prescribing decisions with confidence.



Similar Items



Customer Reviews
Be the first to review this product



Browse Titles In Related Subjects

Additional Description

1. Diuretics in congestive heart failure.

2. Use of digoxin in the treatment of heart failure.

3. Renin-angiotensin system and angiotensin converting enzyme inhibitors in chronic heart failure.

4. Angiotensin receptor blockers in the treatment of heart failure.

5. Beta blockers.

6. Aldosterone antagonism in the pharmacological management of chronic heart failure.

7. Inotropic therapy in clinical practice.

8. Antiarrhythmic therapy in heart failure.

9. Treating the hypercoagulable state of heart failure: modifying the risk of arterial and venous thromboembolism.

10. Vasodilator and nitrates.

11. Natriuretic peptides for the treatment of heart failure.

12. Immune modulatory t herapies in heart failure: using myocarditis to gain mechanistic insights.

13. The role of vasopressin and vasopressin antagonists in heart failure.

14. Role of erythropoietin in the correction of anemia in patients with heart failure.

15. Endothelin antagonism in cardiovascular disease.

16. Pharmacogenetics.

17. Management of diastolic dysfunction.

18. Multidrug pharmacy for treatment of heart failure: an algorithm for the clinician.

Index